Shee et al. analyzed the correlation between tumor SLFN11 mRNA levels and treatment outcomes in the datasets of 75 ovarian cancer patients treated with primary platinum-based chemotherapy. This evidence concerns the gene SLFN11 and ovarian carcinoma.